Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions.
Keenan JD, See CW, Moncada J, Ayele B, Gebre T, Stoller NE, McCulloch CE, Porco TC, Gaynor BD, Emerson PM, Schachter J, Lietman TM
Reliability of measurements performed by community-drawn anthropometrists from rural Ethiopia.
Ayele B, Aemere A, Gebre T, Tadesse Z, Stoller NE, See CW, Yu SN, Gaynor BD, McCulloch CE, Porco TC, Emerson PM, Lietman TM, Keenan JD
Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
Gebre T, Ayele B, Zerihun M, Genet A, Stoller NE, Zhou Z, House JI, Yu SN, Ray KJ, Emerson PM, Keenan JD, Porco TC, Lietman TM, Gaynor BD
Risk factors for ocular chlamydia after three mass azithromycin distributions.
Ayele B, Gebre T, Moncada J, House JI, Stoller NE, Zhou Z, Porco TC, Gaynor BD, Emerson PM, Schachter J, Keenan JD
Chlamydial infection during trachoma monitoring: are the most difficult-to-reach children more likely to be infected?
Keenan JD, Moncada J, Gebre T, Ayele B, Chen MC, Yu SN, Emerson PM, Stoller NE, McCulloch CE, Gaynor BD, Schachter J
Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma.
Keenan JD, Ayele B, Gebre T, Moncada J, Stoller NE, Zhou Z, Porco TC, McCulloch CE, Gaynor BD, Emerson PM, Schachter J, Lietman TM